 HACKENSACK, NJ ACCESSWIRE March 11, 2021 Champions Oncology, Inc. NASDAQ:CSBR, a leading global oncology technology solutions provider engaged in transforming drug discovery and development through data-driven research strategies and innovative pharmacology, biomarker and data platforms, today announced its financial results for the third fiscal quarter ended January 31, 2021. Third Quarter and Recent Highlights: Delivered record quarterly revenue of 10.8 million, an increase of 20 year over year Reported non-GAAP income from operations, excluding stock-based compensation, depreciation and amortization, of 1.3 million Expanded Lumin Bioinformatics proprietary SaaS platform with proteomic module integration Ronnie Morris, CEO of Champions, commented, We are pleased with our third quarter results and we continue to execute our long term strategy of investing in the development of new products and services to increase our revenue streams. 